请使用支持JavaScript的浏览器! Medchemexpress/Ivacaftor(Synonyms: VX-770)/HY-13017/5mg_蚂蚁淘,【正品极速】生物医学科研用品轻松购|ebiomall 蚂蚁淘商城
商品信息
联系客服
Medchemexpress/Ivacaftor(Synonyms: VX-770)/HY-13017/5mg
郑重提醒:
无质量问题不接受退换货,下单前请仔细核对信息。
下单后请及时联系客服核对商品价格,订单生效后再付款。
Medchemexpress/Ivacaftor(Synonyms: VX-770)/HY-13017/5mg
美元价:
(友情提示:该价格仅为参考,欢迎联系客服询价!)
数    量:
免费咨询热线
4000-520-616
IvacaftorisanorallybioavailableCFTRpotentiator,usedforcysticfibrosistreatment.
Description

IvacaftorisanorallybioavailableCFTRpotentiator,usedforcysticfibrosistreatment.

InVitro

Ivacaftor(10 µM)increasesthePCsecretionactivityby3-foldforABCB4-G535D,13.7-foldforABCB4-G536R,6.7-foldforABCB4-S1076C,9.4-foldforABCB4-S1176L,and5.7-foldforABCB4-G1178S.IvacaftorcorrectsthefunctionaldefectofABCB4mutants[1].Ivacaftor(10μM)significantlyincreasesCFTRactivityinW1282X-expressingcellscomparedtoR1162XCFTRcells[2].Ivacaftorshowsnosignificantactivityagainst160targetstestedincludingtheGABAAbenzodiazepinereceptor.IvacaftorincreasesthechloridesecretionwithanEC50of0.236±0.200μM,a10-foldshiftinpotencycomparedtotheF508delHBEs[3].Inrecombinantcells,VX-770increasesCFTRchannelopenprobABIlity(Po)inboththeF508delprocessingmutationandtheG551Dgatingmutation.VX-770increasesforskolin-stimulatedITintemperature-correctedF508del-FRTcellsbyappr6-foldwithanEC50of25nM[4].

InVivo

Ivacaftor(1-200mg/kg,p.o.)exhibitsgoodoralbioavailabilityinrat[3].

ClinicalTrial
ViewMoreCollapse
References
  • [1].DelaunayJL,etal.Functionaldefectofvariantsintheadenosinetriphosphate-bindingsitesofABCB4andtheirrescuebythecysticfibrosistransmembraneconductanceregulatorpotentiator,ivacaftor(VX-770).Hepatology.2017Feb;65(2):560-570.

    [2].MutyamV,etal.TherapeuticbenefitobservedwiththeCFTRpotentiator,ivacaftor,inaCFpatienthomozygousfortheW1282XCFTRnonsensemutation.JCystFibros.2017Jan;16(1):24-29.

    [3].HADIdaS,etal.DiscoveryofN-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide(VX-770,ivacaftor),apotentandorallybioavailableCFTRpotentiator.JMedChem.2014Dec11;57(23):9776-95

    [4].VanGoorF,etal.RescueofCFairwayepithelialcellfunctioninvitrobyaCFTRpotentiator,VX-770.ProcNatlAcadSciUSA.2009Nov3;106(44):18825-30.

PreparingStockSolutions
ConcentrationVolumeMass1mg5mg10mg
1mM2.5478mL12.7392mL25.4784mL
5mM0.5096mL2.5478mL5.0957mL
10mM0.2548mL1.2739mL2.5478mL
Pleaserefertothesolubilityinformationtoselecttheappropriatesolvent.
References
  • [1].DelaunayJL,etal.Functionaldefectofvariantsintheadenosinetriphosphate-bindingsitesofABCB4andtheirrescuebythecysticfibrosistransmembraneconductanceregulatorpotentiator,ivacaftor(VX-770).Hepatology.2017Feb;65(2):560-570.

    [2].MutyamV,etal.TherapeuticbenefitobservedwiththeCFTRpotentiator,ivacaftor,inaCFpatienthomozygousfortheW1282XCFTRnonsensemutation.JCystFibros.2017Jan;16(1):24-29.

    [3].HadidaS,etal.DiscoveryofN-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide(VX-770,ivacaftor),apotentandorallybioavailableCFTRpotentiator.JMedChem.2014Dec11;57(23):9776-95

    [4].VanGoorF,etal.RescueofCFairwayepithelialcellfunctioninvitrobyaCFTRpotentiator,VX-770.ProcNatlAcadSciUSA.2009Nov3;106(44):18825-30.

MolecularWeight

392.49

Formula

C₂₄H₂₈N₂O₃

CASNo.

873054-44-5

Storage
Powder-20°C3years
 4°C2years
Insolvent-80°C6months
 -20°C1month
Shipping

RoomtemperatureincontinentalUS;mayvaryelsewhere

Solvent&Solubility

10mMinDMSO

*"<1 mg/ml"="" means="" slightly="" soluble="" or="" insoluble.="" "≥"="" means="" soluble,="" but="" saturation="">

Purity:99.75%